Connect with us
Researchers developed a highly sensitive (99%) liquid biopsy blood test to detect HPV-related head and neck cancers. By identifying circulating tumor DNA post-surgery, it enables early...
Researchers from INCLIVA developed a blood-based test, TAV16, to detect micrometastases in early-stage colon cancer with unprecedented sensitivity. Using ctDNA analysis, it predicts relapse risk more...
The pharmaceutical company Diesse is developing a new blood test that could track COVID-19 antibodies. The company said the test should be ready by the end...